The application of therapeutic herbs in treatment of common infections and diseases has gained popularity in developing nations due to its cost-effectiveness and purported lower side effects compared to synthetic drug...The application of therapeutic herbs in treatment of common infections and diseases has gained popularity in developing nations due to its cost-effectiveness and purported lower side effects compared to synthetic drugs.Fagara zanthoxyloides Lam also known as Zanthoxylum zanthoxyloides,is an indigenous plant used widely as chewing stick for tooth cleaning in West Africa.The root-bark macerations,decoctions or infusions are the most valuable organs widely taken to treat malaria and diabetes by local populations,traditional healers and local pharmaceutical firms.Searching alternative,more efficient,safer,and less expensive anti-diabetic natural products from plants has received great attention,hence this research delved into the inhibitory effects of the ethyl acetate fraction of F.zanthoxyloides root-bark(EAFFZRB)on in-vitroα-amylase andα-glucosidase enzymes.Standard biochemical methods were used to extract and assess the in-vitro antioxidant such as 2,2-diphenyl-1-picrylhydrazl(DPPH),total antioxidant capacity(TAC)and Ferric Reducing Antioxidant Power(FRAP).The sample was combined at different concentrations(10,20,40,80,160,320,and 640μl/dl).Theα-amylase,andα-glucosidase activities of EAFFZRB sample was combined at different concentrations(0.2,0.4,0.6,0.8 and 1.0 mg/mL).The phyto-constituents in EAFFZRB were identified using Gas Chromatography-Mass Spectrometry(GC-MS)technique.The plant fraction showed a significant(P<0.05)increase in the inhibition ofα-amylase IC50=0.726 andα-glucosidase IC50=0.877 at varying concentrations,comparable to the reference drug Acarbose IC50=0.728 and IC50=0.852 respectively.EAFFZRB demonstrated significant(P<0.05)inhibition at different concentrations on DPPH(66.55±1.57),TAC(0.47±0.17)and FRAP(3.64±0.14),similar to the effect of the standard ascorbic acid.The GC-MS analysis of EAFFZRB revealed a total of 12 volatile organic compounds such as;Phenol-3-methoxy-2,5,6-trimethyl,2-Hydroxy-5-nitrobenzylbromide,2,6-Dimethyl-4-(3-nitrophenyl)pyridine,1H-Benz[e]indene,2-methyl and others.The study confirmed the in-vitro anti-diabetic and anti-oxidant properties of EAFFZRB,supporting the traditional use of the plant which might have acted additively or in synergy towards potentiating of antidiabetic effect observed,and it could be beneficial to the pharmaceutical industry if utilized.展开更多
文摘The application of therapeutic herbs in treatment of common infections and diseases has gained popularity in developing nations due to its cost-effectiveness and purported lower side effects compared to synthetic drugs.Fagara zanthoxyloides Lam also known as Zanthoxylum zanthoxyloides,is an indigenous plant used widely as chewing stick for tooth cleaning in West Africa.The root-bark macerations,decoctions or infusions are the most valuable organs widely taken to treat malaria and diabetes by local populations,traditional healers and local pharmaceutical firms.Searching alternative,more efficient,safer,and less expensive anti-diabetic natural products from plants has received great attention,hence this research delved into the inhibitory effects of the ethyl acetate fraction of F.zanthoxyloides root-bark(EAFFZRB)on in-vitroα-amylase andα-glucosidase enzymes.Standard biochemical methods were used to extract and assess the in-vitro antioxidant such as 2,2-diphenyl-1-picrylhydrazl(DPPH),total antioxidant capacity(TAC)and Ferric Reducing Antioxidant Power(FRAP).The sample was combined at different concentrations(10,20,40,80,160,320,and 640μl/dl).Theα-amylase,andα-glucosidase activities of EAFFZRB sample was combined at different concentrations(0.2,0.4,0.6,0.8 and 1.0 mg/mL).The phyto-constituents in EAFFZRB were identified using Gas Chromatography-Mass Spectrometry(GC-MS)technique.The plant fraction showed a significant(P<0.05)increase in the inhibition ofα-amylase IC50=0.726 andα-glucosidase IC50=0.877 at varying concentrations,comparable to the reference drug Acarbose IC50=0.728 and IC50=0.852 respectively.EAFFZRB demonstrated significant(P<0.05)inhibition at different concentrations on DPPH(66.55±1.57),TAC(0.47±0.17)and FRAP(3.64±0.14),similar to the effect of the standard ascorbic acid.The GC-MS analysis of EAFFZRB revealed a total of 12 volatile organic compounds such as;Phenol-3-methoxy-2,5,6-trimethyl,2-Hydroxy-5-nitrobenzylbromide,2,6-Dimethyl-4-(3-nitrophenyl)pyridine,1H-Benz[e]indene,2-methyl and others.The study confirmed the in-vitro anti-diabetic and anti-oxidant properties of EAFFZRB,supporting the traditional use of the plant which might have acted additively or in synergy towards potentiating of antidiabetic effect observed,and it could be beneficial to the pharmaceutical industry if utilized.
